Follow The Filings

ENOV Enovis Corporation

Health Care, filed as ENOVIS CORPORATION (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.1%
  • $916K

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Mason Hawkins, Southeastern Asset Management). Not free-float ownership.

  1. Mason Hawkins 0.05%

Who owns ENOV

Sorted by value, long equity only, as of 2026 Q2.

History
Mason Hawkins, Southeastern Asset Management 0.05% Hold 44,258 $916K History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ENOV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ENOV insider trades
  • $762K bought by 3 insiders
  • $45K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Oliver Engert Chief Administrative Officer
    Buy
    $50K 2,660 shares at $18.80 +4.3% to stake
    Traded Sep 4 Filed Sep 8
  2. Oliver Engert Chief Administrative Officer
    Buy
    $150K 7,598 shares at $19.74 +14% to stake
    Traded Sep 2–3 Filed Sep 4
  3. Damien McDonald CEO
    Buy
    $250K 13,035 shares at $19.15 +5.6% to stake
    Traded Sep 4 Filed Sep 4
  4. Oliver Engert Chief Administrative Officer
    Buy
    $21K 1,000 shares at $20.92 +1.9% to stake
    Traded Jun 15 Filed Jun 16
  5. Oliver Engert Chief Administrative Officer
    Buy
    $26K 1,200 shares at $21.62 +2.4% to stake
    Traded Jun 11 Filed Jun 15
  6. Oliver Engert Chief Administrative Officer
    Buy
    $23K 1,000 shares at $23.00 +2% to stake
    Traded Jun 10 Filed Jun 11
  7. Oliver Engert Chief Administrative Officer
    Buy
    $22K 1,000 shares at $22.22 +2.1% to stake
    Traded Jun 1 Filed Jun 3
  8. Oliver Engert Chief Administrative Officer
    Buy
    $24K 1,000 shares at $23.74 +2.1% to stake
    Traded Mar 13 Filed Mar 16
  9. Oliver Engert Chief Administrative Officer
    Buy
    $24K 1,000 shares at $23.93 +2.1% to stake
    Traded Mar 10 Filed Mar 12
  10. Oliver Engert Chief Administrative Officer
    Buy
    $42K 1,750 shares at $23.83 +3.9% to stake
    Traded Mar 6–9 Filed Mar 10
  11. Oliver Engert Chief Administrative Officer
    Buy
    $31K 1,250 shares at $24.84 +2.9% to stake
    Traded Mar 3–4 Filed Mar 5
  12. Oliver Engert Chief Administrative Officer
    Buy
    $26K 1,000 shares at $25.50 +2.3% to stake
    Traded Feb 27 Filed Mar 3
  13. Daniel A Pryor Insider
    Sale
    $45K 1,665 shares at $27.21
    Traded Dec 9, 2025 Filed Dec 11, 2025
  14. John Kleckner Principal Accounting Officer
    Buy
    $75K 2,468 shares at $30.32 +25% to stake
    Traded Nov 25, 2025 Filed Nov 28, 2025

Also filed in the last 12 months, not counted as buying or selling: 22 stock grants and 22 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 7.01,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02,5.07,9.01
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
DEF 14A
DEFA14A
SCHEDULE 13G/A —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.71B $2.11B $2.25B
Gross profit $0.991B $1.18B $1.35B
Gross margin * 58.0% 56.0% 59.8%
Net income -$0.033B -$0.825B -$1.18B
Net margin * -1.9% -39.2% -52.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.897B $1.15B $1.21B
Total non-current assets * $3.61B $3.57B $2.63B
Total assets $4.51B $4.72B $3.83B
Total current liabilities $369.61M $529M $598.47M
Total non-current liabilities * $0.719B $1.63B $1.74B
Total equity $3.42B $2.56B $1.49B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $134.99M $113.5M $217.29M
Cash from investing -$242.47M -$955.47M -$179.37M
Cash from financing $127.8M $846.82M -$52.4M
Net change in cash $20.54M $3.34M -$11.78M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.